ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,493.70
0.55%
S&P ASX All Technology
3,942.30
0.62%
Brent Oil
75.43
-0.65%
US Dollar vs AUD
1.60862
0.36%
Bitcoin
104,983.81
1.20%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Theranexus SA (ALTHX) Share Price

Theranexus SA

Theranexus SA (ALTHX)

EU
0.54
0.00
(0.00%)
Closed 30 January 3:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.54
Bid
0.54
Offer
0.54
Volume
0.00
0.00 Day's Range 0.00
0.46 52 Week Range 1.348
Market Cap
4.19M
Previous Close
0.54
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
66,899
Shares Outstanding
7,758,724
Dividend Yield
-
PE Ratio
-0.61
Earnings Per Share (EPS)
-0.88
Revenue
298k
Net Profit
-6.83M

About Theranexus SA

Sector
Medicinal Chems,botanicl Pds
Industry
Medicinal Chems,botanicl Pds
Website
www.theranexus.com
Headquarters
Lyon, Rhone, Fra
Founded
-
Theranexus SA is listed in the Medicinal Chems,botanicl Pds sector of the Euronext with ticker ALTHX. The last closing price for Theranexus was 0.54 €. Over the last year, Theranexus shares have traded in a share price range of 0.46 € to 1.348 €.

Theranexus currently has 7,758,724 shares in issue. The market capitalisation of Theranexus is 4.19 € million. Theranexus has a price to earnings ratio (PE ratio) of -0.61.

Ask ADVFN Intelligence (AI)

ALTHX Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.016-2.877697841730.5560.560.512307180.54405355DE
4-0.05-8.474576271190.590.7140.5041037780.61498585DE
120.0469.311740890690.4940.750.46668990.60373019DE
26-0.16-22.85714285710.70.750.46416320.59554685DE
52-0.34-38.63636363640.881.3480.46343430.75139409DE
156-2.78-83.7349397593.323.640.46245551.42217505DE
260-3.16-85.40540540543.723.60.46350546.88159905DE

ALTHX - Frequently Asked Questions (FAQ)

What is the current Theranexus share price?
The current share price of Theranexus is 0.54 €
How many Theranexus shares are in issue?
Theranexus has 7,758,724 shares in issue
What is the market cap of Theranexus?
The market capitalisation of Theranexus is EUR 4.19M
What is the 1 year trading range for Theranexus share price?
Theranexus has traded in the range of 0.46 € to 1.348 € during the past year
What is the PE ratio of Theranexus?
The price to earnings ratio of Theranexus is -0.61
What is the cash to sales ratio of Theranexus?
The cash to sales ratio of Theranexus is 14.06
What is the reporting currency for Theranexus?
Theranexus reports financial results in EUR
What is the latest annual turnover for Theranexus?
The latest annual turnover of Theranexus is EUR 298k
What is the latest annual profit for Theranexus?
The latest annual profit of Theranexus is EUR -6.83M
What is the registered address of Theranexus?
The registered address for Theranexus is PEPINIERE LAENNEC 60 AVENUE ROCKEFELLER, LYON, RHONE, 69008
What is the Theranexus website address?
The website address for Theranexus is www.theranexus.com
Which industry sector does Theranexus operate in?
Theranexus operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABCAABC Arbitrage
5.09 €
(0.00%)
0
ABAb Science
1.65 €
(0.00%)
0
AALBAalberts NV
34.14 €
(0.00%)
0
AAAAlan Allman Associates
5.90 €
(0.00%)
0
74SW74Software SA
26.80 €
(0.00%)
0
ABCAABC Arbitrage
5.09 €
(0.00%)
0
ABAb Science
1.65 €
(0.00%)
0
AALBAalberts NV
34.14 €
(0.00%)
0
AAAAlan Allman Associates
5.90 €
(0.00%)
0
74SW74Software SA
26.80 €
(0.00%)
0
ABCAABC Arbitrage
5.09 €
(0.00%)
0
ABAb Science
1.65 €
(0.00%)
0
AALBAalberts NV
34.14 €
(0.00%)
0
AAAAlan Allman Associates
5.90 €
(0.00%)
0
74SW74Software SA
26.80 €
(0.00%)
0

Discussion

View Full Feed
Killmaril Killmaril 5 minutes ago
Manipulation here.. It´s done. Trumpet don´t like China. Ai manipulation with price... And many other stock...It sad..
TANH
jeunke22 jeunke22 9 minutes ago
https://www.linkedin.com/posts/cesarconda_pentagon-nationalsecurity-foreignpolicy-activity-7290508326080040960-U9h3?utm_source=share&utm_medium=member_android
NB
Plato_ Plato_ 9 minutes ago
Greetings, iamadog! You make great points. Thank you for them. I would like to expand on longevity and no dilution. VeeMost was founded in 2002 according to its https://veemost.com/about-veemost/ website . So, its longevity to date is about 23 years. Veemost has been a public company for 2 years.
GDVM
gdl gdl 24 minutes ago
Middle of a despot's total control of this country and you only see profits. Like a pandemic declared and everyone ignored it. NO ONE can ever argue the facts on Trump, can they. they might approve or think it benefits them BUT not that he is a MONSTER.

Trump has 2 years to fix the
SPY
rbtree rbtree 30 minutes ago
Ummm, hate to break it to ya, but that is old news from over a year ago...

Meanwhile, this pig bounces between .000001 and .0001... does it even have a bid anymore?
KEGS
jeunke22 jeunke22 33 minutes ago
Just to prove that we need more low latency, bandwidth and speed …. This is the answer to a simple question:
“ Sorry, DeepSeek search service is busy. Please disable search or try again later.”
LWLG
gdl gdl 37 minutes ago
Not only has all 3 branches of government greedily abandoned their pledge they also have lost their souls. I warned, no insisted this was happening. it spells the end of our Republic and end of the stock market. no not for a year or 5 but for decades. The godlike Trump flexes and extends his muscl
RuudSaltis RuudSaltis 42 minutes ago
That’s why he needs only 6 months….! He has a razer sharp plan. It’s amazing how he communicates also one on one with shareholders…
LWLG
wagner wagner 42 minutes ago
I would bet no smart money in before the Exim in on stage... 
NB
Truenorth2016 Truenorth2016 46 minutes ago
Just a Reminder to you and anyone lurking, we just saw the Quantum Computing Healthcare stock RG*ti run from .66 cents to $21.00 in a few months. What people need to understand is GCAN already told us they are being approach by companies for a Quantum Computing /AI merger "BUT" I the CEO never told
GCAN
ramfan60 ramfan60 49 minutes ago
What's wrong with the wingnut? You must be happy with the wonderful job our FDA and NIH have done regulating our food and nutrition over the past 50 years. RFK is passionate about Making America Healthy Again......I'm all for it and he can't get confirmed fast enough as far as I'm concerned.
AMRN
ron_66271 ron_66271 55 minutes ago
Thank for Supporting My Argument.

JPM didn’t have the money to cover Lehman’s ‘Market to Market’ of $17 Billion on September 14th.

Need more?

“BlackRock?”
Why…


All Classes are in the Money.



Ron
JPM
Zorax Zorax 56 minutes ago
He's going to sell them shitface bibles.
Doc logic Doc logic 57 minutes ago
exwannabe,

Simply put: Crossover to an active substance instead of placebo required that the active substance being utilized in the crossover be measured against a comparable group being treated with anything other than a known active substance. Comparators had to be changed when SO
NWBO
ron_66271 ron_66271 1 hour ago
CTS are in the Same Camp as Preferred Shares.

Securitized by Derivative Contracts.

You didn’t understand the Derivative Market Meltdown of 2008.

Lehman’s wasn’t the problem.
JPM was.



Ron
JPM
littlejohn littlejohn 1 hour ago
Traders who played other big names for

Wednesday could start back in

here on the cheapies...

META and MSFT make a lot of money...

And can spend on Ai - R and D...

Seems a good money flow watch...

so we watch..
MSFT
hbhmb hbhmb 1 hour ago
You are right. To much going on behind the scenes. Also the volume ( or lack of such) is causing the swings allowing flippers to flip
Hopefully the next quarters financials will continue improving and with the new web site am hoping we start moving nicely.
AIAD
Wrangler1 Wrangler1 1 hour ago
Wonder why he's deleting posts? Probably  because he realizes he is wrong once again. What an absolute joke. 
WDLF
Golfnut3 Golfnut3 1 hour ago
Thanks for the input...
ALYI
littlejohn littlejohn 1 hour ago
Fine idea, put sellers on 28 turned bullish

on Wednesday with big volume...

https://www.barchart.com/stocks/quotes/SMCI/options?expiration=2025-01-31-w&moneyness=20

those are willing share buyers at 28

if they get exercised with a close on
SMCI
trader53 trader53 1 hour ago
DPLS 0.0004 - Short Squeeze Soon!


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
________________________________________________


https://
DPLS MFI
Plato_ Plato_ 1 hour ago
https://investorshub.advfn.com/uimage/uploads/2025/1/30/jkzcuLinkedIn.png
About us

VeeMost Technologies Inc. is your trusted partner in delivering innovative, customer-focused IT solutions designed to empower your business. As a minority-owned technology provider,
GDVM
blackcat blackcat 1 hour ago
Pretty horrifying situation. Not something you'd think could happen- although it was night and it is a busy airport.

Your Recent History

EU
ALTHX
Theranexus
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads